Wolverine Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Wolverine Trading’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,100	Closed	-$6.73K	–	5407
2023 Q3	$6.73K	Buy	+10,100	New	+$12.4K	﹤0.01%	4377
2022 Q1	–	Sell	-2,547	Closed	-$183K	–	6706
2021 Q4	$183K	Buy	+2,547	New	+$215K	﹤0.01%	4774
2021 Q3	–	Sell	-2,540	Closed	-$283K	–	7157
2021 Q2	$283K	Buy	2,540 +427	+20%	+$41.6K	﹤0.01%	4502
2021 Q1	$187K	Buy	2,113 +576	+37%	+$58.4K	﹤0.01%	5097
2020 Q4	$139K	Buy	+1,537	New	+$131K	﹤0.01%	4380

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wolverine Trading's VBIV Position: Q3 2021 in Review

Wolverine Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2021, closing a stake of 658 shares — an estimated $73K sold.

Wolverine Trading first reported a position in VBIV in Q4 2020 and held it in 3 quarters. The position peaked at $73K in Q2 2021. 126 funds tracked by Wall St. Rank hold VBIV as of Q3 2021.

Wolverine Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2021 after selling out during the quarter.
Wolverine Trading sold 658 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2021, an estimated $73K.
Wolverine Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 3 quarters.
Wolverine Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $73K in Q2 2021.
126 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.